Multiplex Detection Compositions, Methods, and Kits

Abstract

The present invention generally relates to the detection of analytes, particularly biomolecules in samples. The invention also relates to compositions, methods, and kits for detecting the presence of analytes, typically in multiplex detection formats. The invention also relates to methods for determining the presence of at least one analyte in a sample, the methods employing employ single molecule detection techniques to individually detect at least one molecular complex or at least part of a molecular complex.

1 . A method for determining the presence of at least one analyte in a sample, comprising:
 a) amplifying at least one analyte to form at least one analyte surrogate,   b) forming at least one molecular complex comprising (a) the at least one analyte, at least one analyte surrogate, or at least one analyte and at least one analyte surrogate and (b) at least one first linear probe comprising at least one reaction portion and at least one identity portion comprising at least one coded molecular tag; and   c) individually detecting the at least one molecular complex or at least part of at least one molecular complex to determine the presence of the at least one analyte in the sample.   
     
     
         2 . The method of  claim 1 , wherein the molecular complex further comprises at least one second probe comprising at least one reaction portion and at least one analytical portion. 
     
     
         3 . The method of  claim 1 , wherein the at least one identity portion comprises a multiplicity of fluorescent reporter groups. 
     
     
         4 . The method of  claim 1 , wherein the at least one identity portion comprises at least one peptide nucleic acid (PNA), at least one pseudocomplementary peptide nucleic acid (pcPNA), at least one dendrimer, or combinations thereof. 
     
     
         5 . The method of  claim 1 , wherein the at least one identity portion further comprises at least one affinity tag, at least one mobility modifier, or at least one affinity tag and at least one mobility modifier. 
     
     
         6 . The method of  claim 1 , wherein the at least one identity portion is within, coextensive with, or overlaps at least part of the reaction portion of the second probe. 
     
     
         7 . The method of  claim 1 , wherein the at least one analytical portion is within, coextensive with, or overlaps at least part of the reaction portion of the second probe. 
     
     
         8 . The method of  claim 1 , wherein the at least one analytical portion comprises at least one PNA, at least one pcPNA, at least one reporter group, or combinations thereof. 
     
     
         9 . The method of  claim 1 , wherein the at least one analytical portion comprises at least one fluorophore, at least one mobility modifier, at least affinity tag, or combinations thereof. 
     
     
         10 . The method of  claim 1 , wherein at least part of the reaction portion of the at least one first probe and at least part of the reaction portion of the at least one second probe hybridize to complementary sequences on the same strand comprising of the at least one analyte, the at least one analyte surrogate of the at least one analyte and at least one analyte surrogate. 
     
     
         11 . The method of  claim 10 , wherein the at least part of the reaction portion of the at least one first probe and the at least part of the reaction portion of the at least one second probe hybridize adjacent to one another. 
     
     
         12 . The method of  claim 11 , further comprising at least one ligation agent. 
     
     
         13 . The method of  claim 12 , wherein the at least one ligation agent comprises at least one DNA ligase, at least one RNA ligase, or combinations thereof. 
     
     
         14 . The method of  claim 13 , wherein the at least one DNA ligase, the at least one RNA ligase, or both the at least one DNA ligase and the at least one RNA ligase comprises at least one thermostable ligase. 
     
     
         15 . The method of  claim 1 , wherein the at least one analyte comprises at least one nucleic acid sequence comprising at least one ribonucleotide, at least one deoxyribonucleotide, or at least one ribonucleotide and at least one deoxyribonucleotide. 
     
     
         16 . The method of  claim 1 , wherein the at least one analyte comprises at least one nucleic acid sequence comprising at least one heritable mutation, at least one somatic mutation, or at least one heritable mutation and at least one somatic mutation. 
     
     
         17 . The method of  claim 1 , wherein the individually detecting comprises at least one scanning probe microscopy technique, at least one applied optical spectroscopy technique, or both at least one scanning probe microscopy technique and at least one applied optical spectroscopy technique. 
     
     
         18 . The method of  claim 1 , wherein individually detecting comprises attaching at least one molecular complex or at least part of a molecular complex, tethering at least one molecular complex or at least part of a molecular complex, or both attaching and tethering at least one molecular complex or at least part of a molecular complex directly or indirectly to a substrate and individually detecting the at least one molecular complex or at least part of a molecular complex using laser-confocal microscopy; wherein at least one molecular complex comprises a multiplicity of fluorescent reporter group species; and wherein the analyte comprises at least one nucleic acid sequence comprising at least one ribonucleotide, at least one deoxyribonucleotide, at least one heritable mutation, at least one somatic mutation, at least one diagnostic indicator, at least one foreign antigen, at least one drug, at least one metabolite, at least one small molecule, or combinations thereof. 
     
     
         19 . The method of  claim 1 , wherein the at least one molecular complex or at least part of a molecular complex is individually detected in solution using laser-confocal microscopy; and wherein the analyte comprises at least one nucleic acid sequence comprising at least one ribonucleotide, at least one deoxyribonucleotide, at least one heritable mutation, at least one somatic mutation, at least one diagnostic indicator, at least one foreign antigen, at least one drug, at least one metabolite, at least one small molecule, or combinations thereof.